Individualized dosimetry for theranostics: necessary, nice to have, or counterproductive?
U Eberlein, M Cremonesi… - Journal of Nuclear …, 2017 - Soc Nuclear Med
In 2005, the term theragnostics (theranostics) was introduced for describing the use of
imaging for therapy planning in radiation oncology. In nuclear medicine, this expression …
imaging for therapy planning in radiation oncology. In nuclear medicine, this expression …
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association …
RM Tuttle, S Ahuja, AM Avram, VJ Bernet, P Bourguet… - Thyroid, 2019 - liebertpub.com
Background: Publication of the 2015 American Thyroid Association (ATA) management
guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met …
guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met …
[HTML][HTML] Bone metastases from differentiated thyroid carcinoma: current knowledge and open issues
A Nervo, A Ragni, F Retta, M Gallo, A Piovesan… - Journal of …, 2021 - Springer
Bone represents the second most common site of distant metastases in differentiated thyroid
cancer (DTC). The clinical course of DTC patients with bone metastases (BM) is quite …
cancer (DTC). The clinical course of DTC patients with bone metastases (BM) is quite …
[PDF][PDF] SNMMI procedure standard/EANM practice guideline for nuclear medicine evaluation and therapy of differentiated thyroid cancer: abbreviated version
AM Avram, L Giovanella, B Greenspan, SA Lawson… - 2022 - Soc Nuclear Med
Editor's note: SNMMI and the European Association of Nuclear Medicine periodically define
new standards/guidelines for nuclear medicine practice to help advance the science of …
new standards/guidelines for nuclear medicine practice to help advance the science of …
Tumor response to radiopharmaceutical therapies: the knowns and the unknowns
Radiopharmaceutical therapy (RPT) is defined as the delivery of radioactive atoms to tumor-
associated targets. In RPT, imaging is built into the mode of treatment since the …
associated targets. In RPT, imaging is built into the mode of treatment since the …
Differentiated thyroid cancer theranostics: radioiodine and beyond
PS Choudhury, M Gupta - The British journal of radiology, 2018 - birpublications.org
The term theranostics is the combination of a diagnostic tool that helps to define the right
therapeutic tool for specific disease. It signifies the “we know which sites require treatment …
therapeutic tool for specific disease. It signifies the “we know which sites require treatment …
[HTML][HTML] Redifferentiation-facilitated radioiodine therapy in thyroid cancer
L Lamartina, N Anizan, C Dupuy… - Endocrine-Related …, 2021 - erc.bioscientifica.com
Based on experimental data, the inhibition of the MAPkinase pathway in patients with
radioiodine-refractory thyroid cancer was capable of inducing a redifferentiation. Preliminary …
radioiodine-refractory thyroid cancer was capable of inducing a redifferentiation. Preliminary …
[HTML][HTML] Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey
K Sjögreen Gleisner, E Spezi, P Solny, PM Gabina… - EJNMMI physics, 2017 - Springer
Background Currently, the implementation of dosimetry in molecular radiotherapy (MRT) is
not well investigated, and in view of the Council Directive (2013/59/Euratom), there is a need …
not well investigated, and in view of the Council Directive (2013/59/Euratom), there is a need …
[HTML][HTML] Standardised quantitative radioiodine SPECT/CT imaging for multicentre dosimetry trials in molecular radiotherapy
RA Gregory, I Murray, J Gear, F Leek… - Physics in Medicine …, 2019 - iopscience.iop.org
Abstract The SEL-I-METRY trial (EudraCT No 2015-002269-47) is the first multicentre trial to
investigate the role of 123 I and 131 I SPECT/CT-based tumour dosimetry to predict …
investigate the role of 123 I and 131 I SPECT/CT-based tumour dosimetry to predict …
Comparison of empiric versus whole-body/-blood clearance dosimetry–based approach to radioactive iodine treatment in patients with metastases from differentiated …
D Deandreis, C Rubino, H Tala… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The optimal management of radioactive iodine (RAI) treatment in patients with metastatic
thyroid cancer (TC) is still a matter of debate. Methods: We retrospectively analyzed 352 …
thyroid cancer (TC) is still a matter of debate. Methods: We retrospectively analyzed 352 …